GE HealthCare
GE HealthCare Technologies Inc.
NASDAQ: GEHC. Canonical company identity and public leadership record.
US
- Alpha ID
- alpha:company:7adcaf96-ef73-4714-af48-2001512c4375
- SEC CIK
- 0001932393
- Website
- www.gehealthcare.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
- Newest evidence
- May 3, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Jeannette BankesPresident and CEO, Patient Care Solutions
- Chair
- H. Lawrence Culp JrLead independent: Risa Lavizzo-Mourey
- Independent
- Not published11 directors published
- Published claims
- 437 distinct sources
- Evidence records
- 250 pinned
- Source conflicts
- 0None open
Built from 7 distinct sources and 25 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
Kevin A. Lobo seat on GE HealthCare, effective 2026-01-01.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief People Officer | Adam Y. Holton | Not captured | unknown | Source reportedE14 |
| General Counsel and Corporate Secretary | Frank R. Jimenez | Not captured | unknown | Source reportedE15 |
| Vice President and Chief Financial Officer | James K. Saccaro | Not captured | unknown | Source reportedE16 |
| President and CEO, Patient Care Solutions | Jeannette Bankes | Not captured | unknown | Source reportedE17 |
| President and CEO, Pharmaceutical Diagnostics | Kevin M. O Neill | Not captured | unknown | Source reportedE18 |
| President, Chief Executive Officer, and Director | Peter J. Arduini | Not captured | unknown | Source reportedE19 |
| President and CEO, Advanced Visualization Solutions | Philip Rackliffe | Not captured | unknown | Source reportedE20 |
| President and CEO, Imaging | Roland Rott | Not captured | unknown | Source reportedE21 |
| Chief Science and Technology Officer | Taha Kass-Hout | Not captured | unknown | Source reportedE22 |
Board of directors
Evidence11 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Anne T. Madden | Independence not published | 2023 | AuditAudit; Nominating and GovernanceNominating and Governance | Source reportedE4 |
| Catherine Lesjak | Independence not published | 2022 | Audit, chairAudit · Chair | Source reportedE5 |
| H. Lawrence Culp Jr | Independence not publishedChair | 2018 | None published | Source reportedE3 |
| Kevin A. Lobo | Independence not published | 2026 | Talent, Culture, and Compensation | Source reportedE6 |
| Lloyd W. Howell, Jr. | Independence not published | 2025 | None published | Source reportedE7 |
| Peter J. Arduini | Independence not published | 2022 | None published | Source reportedE8 |
| Phoebe L. Yang | Independence not published | 2023 | AuditAudit; Nominating and GovernanceNominating and Governance | Source reportedE9 |
| Risa Lavizzo-Mourey | Independence not publishedLead Independent | 2025 | None published | Source reportedE10 |
| Rodney F. Hochman | Independence not published | 2023 | Nominating and GovernanceNominating and Governance; Talent, Culture, and CompensationTalent, Culture, and Compensation | Source reportedE11 |
| Tomislav Mihaljevic | Independence not published | 2025 | None published | Source reportedE12 |
| William J. Stromberg | Independence not published | 2023 | AuditAudit; Talent, Culture, and Compensation · ChairTalent, Culture, and Compensation, chair | Source reportedE13 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Catherine Lesjak | Catherine Lesjak, Anne T. Madden, Phoebe L. Yang, William J. Stromberg | Not described in the published record |
| Audit · Chair | Not published | Catherine Lesjak | Not described in the published record |
| Audit; Nominating and Governance | Not published | Anne T. Madden, Phoebe L. Yang | Not described in the published record |
| Audit; Talent, Culture, and Compensation · Chair | Not published | William J. Stromberg | human_capital |
| Nominating and Governance | Not published | Anne T. Madden, Phoebe L. Yang, Rodney F. Hochman | Not described in the published record |
| Nominating and Governance; Talent, Culture, and Compensation | Not published | Rodney F. Hochman | human_capital |
| Talent, Culture, and Compensation | William J. Stromberg | William J. Stromberg, Kevin A. Lobo, Rodney F. Hochman | human_capital |
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
Evidence| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NASDAQ: GEHC | current | Jan 4, 2023 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
| Nasdaq-100 (Nasdaq) | NASDAQ: GEHC | current | Sep 1, 2026 | exchange verified | Nasdaq official Nasdaq-100 list-type API |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Adam Y. HoltonChief People Officercompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:20
- Frank R. JimenezGeneral Counsel and Corporate Secretarycompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:21
- James K. SaccaroVice President and Chief Financial Officercompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:22
- Jeannette BankesPresident and CEO, Patient Care Solutionscompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:23
- Kevin M. O NeillPresident and CEO, Pharmaceutical Diagnosticscompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:24
- Peter J. ArduiniPresident, Chief Executive Officer, and Directorcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:25, company:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:14
- Philip RackliffePresident and CEO, Advanced Visualization Solutionscompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:26
- Roland RottPresident and CEO, Imagingcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:27
- Taha Kass-HoutChief Science and Technology Officercompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:28
- Anne T. MaddenDirectorcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:10
- Catherine LesjakDirectorcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:11
- H. Lawrence Culp JrChaircompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:9
- Kevin A. LoboDirectorcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:12
- Lloyd W. Howell, Jr.Directorcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:13
- Phoebe L. YangDirectorcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:15
- Risa Lavizzo-MoureyLead Independent Directorcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:16
- Rodney F. HochmanDirectorcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:17
- Tomislav MihaljevicDirectorcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:18
- William J. StrombergDirectorcompany:7adcaf96-ef73-4714-af48-2001512c4375:leadership_role:19
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 25 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 6 Claims.
- E2GE HealthCare Technologies Inc. Form 10-K (filed 2026-02-04). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec filing. Published Mar 19, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E4sec filing. Published Mar 19, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E5sec filing. Published Mar 19, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E6sec filing. Published Mar 19, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E7sec filing. Published Apr 10, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E8sec filing. Published Mar 19, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E9sec filing. Published Mar 19, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E10sec filing. Published Apr 10, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E11sec filing. Published Mar 19, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E12sec filing. Published Apr 10, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E13sec filing. Published Mar 19, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E14GEHC executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E15GEHC executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E16GEHC executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E17GEHC executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E18GEHC executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E19GEHC executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E20GEHC executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E21GEHC executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E22GEHC executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E23board_seats. sp500-board-director-completeness-remediation-2026-05-15. Cited by 13 Claims.
- E24Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
- E25Nasdaq official Nasdaq-100 list-type API. index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 15, 2026- Kevin A. Lobo seat on GE HealthCare, effective 2026-01-01.
- Kevin A. Lobo member of Talent, Culture, and Compensation, effective 2026-01-01.
- Lloyd W. Howell, Jr. seat on GE HealthCare, effective 2025-04-10.
- Risa Lavizzo-Mourey seat on GE HealthCare, effective 2025-04-10.
- Risa Lavizzo-Mourey lead independent director of GE HealthCare, effective 2025-04-10.
- Tomislav Mihaljevic seat on GE HealthCare, effective 2025-04-10.
- Anne T. Madden seat on GE HealthCare, effective 2023-01-01.
- Phoebe L. Yang seat on GE HealthCare, effective 2023-01-01.
- Rodney F. Hochman seat on GE HealthCare, effective 2023-01-01.
- William J. Stromberg seat on GE HealthCare, effective 2023-01-01.
- Audit; Nominating and Governance committee of GE HealthCare, effective 2023-01-01.
- Anne T. Madden member of Audit; Nominating and Governance, effective 2023-01-01.
- Phoebe L. Yang member of Audit; Nominating and Governance, effective 2023-01-01.
- Audit; Talent, Culture, and Compensation · Chair committee of GE HealthCare, effective 2023-01-01.
- William J. Stromberg member of Audit; Talent, Culture, and Compensation · Chair, effective 2023-01-01.
- Nominating and Governance; Talent, Culture, and Compensation committee of GE HealthCare, effective 2023-01-01.
- Rodney F. Hochman member of Nominating and Governance; Talent, Culture, and Compensation, effective 2023-01-01.
- Catherine Lesjak seat on GE HealthCare, effective 2022-01-01.
- Peter J. Arduini seat on GE HealthCare, effective 2022-01-01.
- Audit · Chair committee of GE HealthCare, effective 2022-01-01.
- Catherine Lesjak member of Audit · Chair, effective 2022-01-01.
- H. Lawrence Culp Jr seat on GE HealthCare, effective 2018-01-01.
- H. Lawrence Culp Jr chairs board GE HealthCare, effective 2018-01-01.

